Contact us on 02033938531 or uk@gentaur.com.

anti-CCL4 Antibody

Basic information

Name

anti-CCL4 Antibody

size

0.05 mg

Catalog number

XW-7720

Price

180 €

Details and extended information

GENE symbol

CCL4

NCBI GENE nr

6351

Antigen

27-92

Works with

Human

Protein nr

P13236

Omim nr

4506845

Quantity per ml

1 mg/mL

Ab raised in

Chicken

French translation

anticorps

Type

Polyclonal

Vial with antibody

in solution

Ncbi nr

NP_002975.1

Source

Homo sapiens

Antibodie's label

unlabelled serum

Immuno application

ELISA, Western Blot

KDa

10.2 kDa (calculated)

Purity

Immunoaffinity Purified

Antigene name

chemokine (C-C motif) ligand 4

Suspention, pH, azide

Phosphate-Buffered Saline. No preservatives added.

Properties

If you buy Antibodies supplied by proscience they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.

Antibody advice

Small inducible cytokine A4 antibody can be used for the detection of Small inducible cytokine A4 by ELISA and Western Blot, may also work for ICC and IHC.

Description

This antibody needs to be stored at + 4°C in a fridge short term in a concentrated dilution. Freeze thaw will destroy a percentage in every cycle and should be avoided.

Keep at

CCL4 antibody can be stored at 4 grades C for short term (weeks). Long term storage should be at -20 grades C. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Gene names

LAG1, MIP1B, SCYA4, C-C motif chemokine 4, G-26 T-lymphocyte-secreted protein, LAG-1, ACT2, G-26, HC21, LAG1, SCYA2, MIP1B1, AT744.1, MIP-1-beta, Small inducible cytokine A4, CCL4, Macrophage inflammatory protein 1-beta, MIP-1-beta(1-69), T-cell activation protein 2, ACT-2, PAT 744, H400, SIS-gamma, Lymphocyte activation gene 1 protein, G-26 T lymphocyte-secreted protein

Gene info

FUNCTION: Monokine with inflammatory and chemokinetic properties. Binds to CCR5. One of the major HIV-suppressive factors produced by CD8+ T cells. Recombinant MIP-1-β induces a dose-dependent inhibition of different strains of HIV-1, HIV-2, and simian immunodeficiency virus (SIV). The processed form MIP-1-β(3-69) retains the abilities to induce down-modulation of surface expression of the chemokine receptor CCR5 and to inhibit the CCR5-mediated entry of HIV-1 in T cells. MIP-1-β(3-69) is also a ligand for CCR1 and CCR2 isoform B.